Literature DB >> 16268263

Subacute cutaneous lupus erythematosus associated with leflunomide.

Anthony R Elias1, Christine C Tam, Kathleen M David-Bajar.   

Abstract

A skin eruption consistent with subacute cutaneous lupus erythematosus (SCLE) occurred in a patient taking leflunomide for rheumatoid arthritis. The eruption resolved after discontinuation of the medication. Suppression of tumor necrosis factor (TNF)-effector mechanisms by leflunomide may have played a role in the pathogenesis of this disorder.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16268263

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  3 in total

1.  Suppressed wound healing in a patient with rheumatoid arthritis taking leflunomide (arava).

Authors:  D Miller Wise
Journal:  Perm J       Date:  2011

2.  Rare Occurrence of Drug Induced Subacute Cutaneous Lupus Erythematosus with Leflunomide Therapy.

Authors:  Harpreet Singh; Gagandeep Sukhija; Vikram Tanwar; Sameer Arora; Jaikrit Bhutani
Journal:  J Clin Diagn Res       Date:  2016-10-01

3.  Jessner-Kanof disease induced by leflunomide: a dermal variant of cutaneous lupus?

Authors:  Laëtitia Sparsa; Naji Afif; Joëlle Goetz; Christelle Sordet; Emmanuel Chatelus; Dan Lipsker; Jean Sibilia
Journal:  Rheumatol Int       Date:  2009-10-13       Impact factor: 2.631

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.